Delivery Order SPE2DB22D3004-SPE2DB24FQB76
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $38,649.41 firm fixed price delivery order is for the pharmaceutical product ADBRY 150 MG/ML SYRINGE. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, holds an indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ADBRY 150 MG/ML SYRINGE. The contract, valued at $4,740.88, is a Firm Fixed Price Delivery Order that will be completed by February 22, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, SPE2DB22D3016|SPE2DB25FAGV0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,508.74 firm fixed-price delivery order is for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price of $3,947.14 and a completion date of January 8, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, will provide the pharmaceutical product ADBRY 150 MG/ML SYRINGEML to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $18,567.28 firm-fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has a period of performance through September 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military healthcare system. This award is likely part of a larger...
- This federal contract award is for the delivery of medical supplies, specifically Adbry 150 mg/ml syringes, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,573.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of December 22, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $4,301.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML, with a completion date of May 3, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,757.64, is for the delivery of the pharmaceutical product ADBRY 150 MG/ML SYRINGE. The contract has an ultimate completion date of June 4, 2024 and is a Firm Fixed Price Delivery Order. There was no set-aside used for this award. Amerisourcebergen Drug Corp is the prime...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $10,444.65 firm fixed price delivery order is for the supply of 4563927361 ! ABRYSVO VIAL WITH DILUENTS, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is for the delivery of a specific pharmaceutical product, ADBRY 300 MG/2 ML AUTOINJECTOR 2ML. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQB76Delivery Order
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQB76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,605.87 firm fixed price delivery order is for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 4/22/24 |